Kirson NY - Search Results

1

Basal insulin persistence, associated factors, and outcomes after treatment initiation among people with type 2 diabetes mellitus in the US.

Perez-Nieves M, Kabul S, Desai U, Ivanova JI, Kirson NY, Cummings AK, Birnbaum HG, Duan R, Cao D, Hadjiyianni I. Perez-Nieves M, et al. Among authors: kirson ny. Curr Med Res Opin. 2016;32(4):669-80. doi: 10.1185/03007995.2015.1135789. Epub 2016 Jan 13. Curr Med Res Opin. 2016. PMID: 26703951

2

Comparing healthcare costs of Medicaid patients with postherpetic neuralgia (PHN) treated with lidocaine patch 5% versus gabapentin or pregabalin.

Kirson NY, Ivanova JI, Birnbaum HG, Wei R, Kantor E, Puenpatom RA, Ben-Joseph RH, Summers KH. Kirson NY, et al. J Med Econ. 2010;13(3):482-91. doi: 10.3111/13696998.2010.506176. J Med Econ. 2010. PMID: 20684669 Free article.

3

Descriptive analysis of Medicaid patients with postherpetic neuralgia treated with lidocaine patch 5%.

Kirson NY, Ivanova JI, Birnbaum HG, Wei R, Kantor E, Amy Puenpatom R, Ben-Joseph RH, Summers KH. Kirson NY, et al. J Med Econ. 2010;13(3):472-81. doi: 10.3111/13696998.2010.499819. J Med Econ. 2010. PMID: 20684670 Free article.

4

Prevalence of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension in the United States.

Kirson NY, Birnbaum HG, Ivanova JI, Waldman T, Joish V, Williamson T. Kirson NY, et al. Curr Med Res Opin. 2011 Sep;27(9):1763-8. doi: 10.1185/03007995.2011.604310. Epub 2011 Jul 27. Curr Med Res Opin. 2011. PMID: 21793646

5

Excess costs associated with patients with pulmonary arterial hypertension in a US privately insured population.

Kirson NY, Birnbaum HG, Ivanova JI, Waldman T, Joish V, Williamson T. Kirson NY, et al. Appl Health Econ Health Policy. 2011 Sep 1;9(5):293-303. doi: 10.2165/11592430-000000000-00000. Appl Health Econ Health Policy. 2011. PMID: 21875160

6

Excess costs associated with patients with chronic thromboembolic pulmonary hypertension in a US privately insured population.

Kirson NY, Birnbaum HG, Ivanova JI, Waldman T, Joish V, Williamson T. Kirson NY, et al. Appl Health Econ Health Policy. 2011 Nov 1;9(6):377-87. doi: 10.2165/11592440-000000000-00000. Appl Health Econ Health Policy. 2011. PMID: 21888449

7

Direct and indirect costs of patients treated with extended-release oxymorphone HCl or controlled-release oxycodone HCl.

Kirson NY, White AG, Birnbaum HG, Schiller M, Waldman T, Peterson K, Ben-Joseph RH, Berner T, Summers KH. Kirson NY, et al. J Med Econ. 2012;15(1):87-95. doi: 10.3111/13696998.2011.629261. Epub 2011 Oct 28. J Med Econ. 2012. PMID: 22032675 Free article.

8

Matching-adjusted indirect comparison of adalimumab vs etanercept and infliximab for the treatment of psoriatic arthritis.

Kirson NY, Rao S, Birnbaum HG, Kantor E, Wei RS, Cifaldi M. Kirson NY, et al. J Med Econ. 2013;16(4):479-89. doi: 10.3111/13696998.2013.768530. Epub 2013 Feb 7. J Med Econ. 2013. PMID: 23339434 Free article.

9

Implications of early treatment among Medicaid patients with Alzheimer's disease.

Geldmacher DS, Kirson NY, Birnbaum HG, Eapen S, Kantor E, Cummings AK, Joish VN. Geldmacher DS, et al. Among authors: kirson ny. Alzheimers Dement. 2014 Mar;10(2):214-24. doi: 10.1016/j.jalz.2013.01.015. Epub 2013 May 2. Alzheimers Dement. 2014. PMID: 23643457

10

Pre-diagnosis excess acute care costs in Alzheimer's patients among a US Medicaid population.

Geldmacher DS, Kirson NY, Birnbaum HG, Eapen S, Kantor E, Cummings AK, Joish VN. Geldmacher DS, et al. Among authors: kirson ny. Appl Health Econ Health Policy. 2013 Aug;11(4):407-13. doi: 10.1007/s40258-013-0038-9. Appl Health Econ Health Policy. 2013. PMID: 23700254

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters